Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.840
-0.105 (-3.57%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $66.01 million as of March 10, 2026. Its market cap has decreased by -56.05% in one year.
Market Cap
66.01M
Enterprise Value
49.09M
1-Year Change
-56.05%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $66.01M, a decrease of -56.61%. That is a compound annual growth rate of -41.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 68.45M | -51.88% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coeptis Therapeutics Holdings | 72.31M |
| XBiotech | 71.65M |
| Cingulate | 71.37M |
| Q32 Bio | 71.25M |
| TScan Therapeutics | 70.56M |
| Annovis Bio | 68.11M |
| MediciNova | 67.93M |
| Impact BioMedical | 66.84M |